Skip to main content
. 2013 Jan;38(1):24–32. doi: 10.1503/jpn.110145

Fig. 1.

Fig. 1

Topographic maps of power (top) and phase-locking factor (PLF; bottom) during the 40 Hz target stimuli when participants were under placebo (left) and dexamphetamine (right). Both power and PLF values were averaged over the period between 100 and 500 ms poststimulus onset.